SEC Form 4 · accession 0001127602-18-028061
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eva C Boratto
Officer — EVP, Cont & Chief Acct Officer
Period of report
Sep 17, 2018
Accepted (ET)
Sep 19, 2018 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 17, 2018 | M | 13,311 | $45.07 | A | 55,162 | D | |
| Common StockF2 | Sep 17, 2018 | S | 13,311 | $77.16 | D | 41,851 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF3 | $45.07 | Sep 17, 2018 | M | 13,311 | D | Apr 2, 2013 | Apr 2, 2019 | Common Stock | 13,311 | 0 | D |
Explanation of responses
- F1All sales were effected pursuant to a Rule 10b5-1 plan.
- F2Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $76.77 and $77.93 per share.
- F3Option became exercisable in four equal annual installments, commencing 4/2/2013.